Overview

Prospective Comparison of Ampicillin / Amoxicillin Versus Ceftriaxone for the Treatment of Salmonella Infections in AIDS Patients

Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
0
Participant gender:
All
Summary
To compare the effectiveness of standard treatment with parenteral ampicillin and oral amoxicillin compared to initial daily therapy with ceftriaxone followed by 3 times weekly suppressive treatment for salmonella infections in AIDS patients.
Phase:
N/A
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
University of Southern California
Treatments:
Amoxicillin
Ampicillin
Ceftriaxone
Criteria
Exclusion Criteria

Co-existing Condition:

Patients with the following are excluded:

- Type I hypersensitivity to beta-lactam antibiotics.

- Not expected to survive 12 weeks.

- In a coma or with other central nervous system (CNS) impairment.

Patients with the following are excluded:

- Type I hypersensitivity to beta-lactam antibiotics.

- Not expected to survive 12 weeks.

- In a coma or with other central nervous system (CNS) impairment.

Prior Medication:

Excluded within 48 hours of study entry:

- Treatment with an antibiotic active in vitro against Salmonella.

HIV infection, AIDS, or AIDS related complex (ARC).

- Salmonella bacteremia or positive stool culture in patient with 3 or more stools per
day.